Exhibit 10.1
THE COMMON STOCK ISSUABLE PURSUANT TO THIS AGREEMENT HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAW. THE
COMMON STOCK ISSUABLE PURSUANT TO THIS AGREEMENT MAY NOT BE SOLD, OFFERED FOR
SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN
EFFECT UNDER SUCH ACT AND SUCH LAWS WITH RESPECT TO THE COMMON STOCK ISSUABLE
PURSUANT TO THIS AGREEMENT, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED.
CAVIT SCIENCES, INC.
COMMON STOCK PURCHASE AGREEMENT
INFORMATION REGARDING CAVIT SCIENCES, INC., INCLUDING ITS PROSPECTUS, FORM 10SB
REGISTRATION AND RELATED FILINGS UNDER THE SECURITIES ACTS OF 1933 AND 1934, ARE
AVAILABLE FOR REVIEW ON THE SEC'S WEBSITE ( WWW.SEC.GOV ) AND ON CAVIT SCIENCES,
INC.'S WEBSITE (WWW.CAVITSCIENCES.COM ).
This COMMON STOCK PURCHASE AGREEMENT ("Agreement") is made this 29th day of
November 2007 by and between CAVIT SCIENCES, INC., a Florida corporation
("CAVIT" or the "Company"), and Vision International Enterprises, S.A. ("Vision"
or "Investor").
Background
As more fully set forth herein, Investor has agreed to purchase from
the Company shares of Common Stock ("Common Stock") and warrants for common
stock ("Warrants") for a purchase price of $250,000. ("Commitment Amount").
Agreement
NOW, THEREFORE, intending to be legally bound hereby, the parties agree as
follows:
1. Commitment. Subject to the terms and conditions hereof, Investor agrees
to purchase 1,250,000 shares of Cavit's Common Stock from Cavit at a purchase
price of $.20 per share and 1,500,000 warrants for Cavit's Common Stock at
strike prices ranging from $.40 to $3.00 per share (see table below) with
varying expiration dates (see table below) from the date of issuance
("Commitment Purchase Amount") not to exceed the Commitment Amount.
TABLE: The number of warrants, class of warrants, exercise price of warrants and
term of warrants are set forth below:
Class No. of Warrants Exercise Price Term
----- --------------- -------------- ----
A 125,000 $ .40 per share 6 months
B 125,000 $ .60 per share 9 months
C 125,000 $ .80 per share 12 months
D 175,000 $1.00 per share 15 months
E 175,000 $1.25 per share 18 months
F 175,000 $1.50 per share 21 months
G 175,000 $1.75 per share 24 months
H 250,000 $2.00 per share 36 months
I 175,000 $3.00 per share 48 months
2. Share Issuance. Upon the payment of the Commitment Purchase Price as
aforesaid, the Company shall issue and cause to be delivered with all reasonable
dispatch to Investor and in the name of Investor, a certificate or certificates
for the number of shares of Common Stock so purchased. Such certificate or
certificates shall be deemed to have been issued and Investor shall be deemed to
have become a holder of record of such Common Stock on and as of the date of the
delivery to the Company of and payment of the Commitment Purchase Price as
aforesaid. If, however, at the date of payment of such Commitment Purchase
Price, the transfer books for the Common Stock shall be closed, the certificates
for the Common Stock shall be issued and Investor shall become a record owner of
such Common Stock on and as of the next date on which such books shall be
opened, and until such date the Company shall be under no duty to deliver any
certificate for such Common Stock.
3. Warrant Issuance. Upon the payment of the Commitment Purchase Price as
aforesaid, the Company shall issue and cause to be delivered with all reasonable
dispatch to Investor and in the name of Investor, warrants for the number of
warrants for Common Stock so purchased. Such warrants shall be deemed to have
been issued and Investor shall be deemed to have become a holder of record of
such warrants on and as of the date of the delivery to the Company of and
payment of the Commitment Purchase Price as aforesaid.
4. Representations by Investor. Investor represents and warrants to the
Company as follows:
a) Investor has relied only upon the information presented and contained in
the Term Sheet provided by the Company ("Offering Materials") and the
INVESTOR HAS READ AND UNDERSTANDS THE INFORMATION CONTAINED IN THE
COMPANY'S PROSPECTUS, FORM 10 SB REGISTRATION AND RELATED FILINGS UNDER THE
SECURITIES ACTS OF 1933 AND 1934, WHICH ARE AVAILABLE ON THE SEC'S WEBSITE
REFERRED TO ABOVE. Investor has had the opportunity to ask of the person or
persons acting on behalf of the Company any and all relevant questions in
connection with any aspect of the Company including, but not limited to,
the Common Stock offered by the Offering Materials and has received answers
which Investor considers to be reasonably responsive to such questions.
Investor has had the opportunity to verify the accuracy of the information
contained in the Offering Materials.
(b) Investor understands that Investor is subscribing for the Common Stock
without being furnished any literature in connection with the Offering
other than the Offering Materials, and that the Offering of the Common
Stock presented in the Offering Materials will not have been scrutinized by
the Securities and Exchange Commission or by the securities administrator
or similar bureau, agency, or department of the state of Investor's'
residence.
(c) Investor understands (i) that the Common Stock has not been registered
under the Securities Act of 1933, as amended ("Act"), or registered or
qualified under the securities laws of the state of Investor's' residence,
(ii) REGISTRATION RIGHTS: upon receipt of a written demand by the Investor,
the Company is obligated to register the shares of Common Stock and
warrants under the Securities Act of 1933, as amended, within limits of
current SEC guidelines.
(d) The Common Stock is being purchased for Investor's own account for
investment purposes only and not for the interest of any other person and
is not being purchased with a view to or for the resale, distribution,
subdivision or fractionalization thereof.
(e) Investor is able to bear the economic risks related to purchase of the
Common Stock for an indefinite period of time (i.e., Investor is able to
afford a complete loss of the Common Stock Investor is subscribing to
purchase). Investor's net worth and assets are sufficient to enable
Investor to purchase shares of Common Stock from Cavit in the amount of the
Commitment Amount pursuant to this Agreement.
(f) Investor's overall commitment to investments which are not readily
marketable is not disproportionate to Investor's net worth and Investor's
investment in the Company will not cause such overall commitment to become
excessive.
(g) Investor has adequate means of providing for Investor's current needs
and possible personal contingencies. Investor has no need for liquidity of
the Common Stock subscribed to be purchased hereby and has no reason to
anticipate any change in Investor's personal circumstances, financial or
otherwise, which might cause or require any sale or distribution of such
Common Stock subscribed to be purchased.
(h) Investor recognizes that the purchase of the Common Stock involves a
high degree of risk including those special risks.
(i) Investor understands that Investor's right to transfer the Common Stock
will be restricted as set forth on the certificate evidencing the Common
Stock. Such restrictions include provisions against transfer unless such
transfer is not in violation of the Act, or applicable state securities
laws (including investor suitability standards).
2
(j) All information which Investor has provided to the Company including,
but not limited to, financial position, and status as an accredited
investor, and knowledge of financial and business matters is true, correct
and complete as of the date of execution of this Agreement. Investor
understands that the Company will rely in a material degree upon the
representations contained herein.
(k) Investor understands that a legend may be placed on any stock
certificate representing the Common Stock substantially to the following
effect:
On the front side:
"Transfer of the shares represented by this certificate is restricted - see
reverse side."
On the reverse side:
"The shares represented by this certificate have been issued to the
registered owner in reliance upon written representations that these shares
have been taken for investment. These shares have not been registered under
the Securities Act of 1933, as amended ("Act"), and may not be sold,
transferred or assigned unless an opinion of counsel satisfactory to the
company has been received by the company to the effect that such sale,
transfer or assignment will not be in violation of the Act and the rules
and regulations promulgated thereunder or applicable state securities
laws."
(l) Investor is an "accredited investor" as defined in Rule 501 promulgated
under the Act because Investor's individual net worth (or Investor's joint
net worth with his spouse) on the date hereof exceeds $1,000,000.
5. Securities Laws. As a condition to the issuance of any Common Stock
pursuant this Agreement, Investor shall execute and deliver such
representations, warranties, and covenants, that may be required by applicable
federal and state securities law, or that the Company determines is reasonably
necessary in connection with the issuance of such Common Stock. In addition, the
certificates representing the Common Stock shall contain such legends, or
restrictive legends, or stop transfer instructions, as shall be required by
applicable Federal or state securities laws, or as shall be reasonably required
by the Company or its transfer agent. The Investor has completed and delivered
an Investor Questionnaire to the Company.
6. Binding Effect. This Agreement shall be binding upon the party's
respective heirs, personal representatives, successors and assigns; provided,
however, that this Agreement shall not be assignable by Investor, in whole or in
part, without the prior consent of the Company.
7. Applicable Law. This Agreement shall be deemed to be a contract made
under the laws of the State of Florida and for all purposes shall be construed
in accordance with the laws thereof regardless of its choice of law rules.
8. Brokers and Finders. Cavit and Investor hereby represent to each other
that no broker or finder has been employed or engaged by either of them in
connection with the transactions contemplated in this Agreement and that all
negotiations relative to this Agreement have been carried on directly between
the parties hereto without the intervention of any other person.
9. Survival of Representations and Warranties, and Remedies. All
representations and warranties contained in this Agreement shall survive the
execution and delivery of this Agreement.
10. Entire Agreement. This Agreement constitutes the entire understanding
and agreement between the parties hereto with respect to the transactions
contemplated herein, supersedes all prior and contemporaneous agreements,
understandings, negotiations and discussions, whether oral or written, of the
parties, and there have been no warranties, representations or promises, written
or oral, made by any of the parties hereto except as herein expressly set forth
herein.
11. Waiver, Modification, etc. Any party to this Agreement may waive any of
the terms or conditions of this Agreement or agree to an amendment or
modification to this Agreement by an agreement in writing executed in the same
manner (but not necessarily by the same persons) as this Agreement. No amendment
or modification of this Agreement shall be binding unless in writing executed by
all of the parties to this Agreement. No waiver of any of the provisions of this
Agreement shall be deemed or shall constitute a waiver of any other provision
hereof (whether or not similar), nor shall any waiver constitute a continuing
waiver unless otherwise expressly provided.
3
12. Funding Date. It is the intention of the Investor to begin funding the
Commitment Purchase Price on or before November 30, 2007.
13. Notice. Any notice or other communications required or permitted
hereunder shall be sufficiently given: (i) three (3) business days after if sent
by certified mail, return receipt requested, postage prepaid, or (ii) one (1)
business day after sent by Federal Express or other overnight courier providing
delivery confirmation for next business day delivery, or (ii) when delivered by
personal delivery, telecopier, or e-mail, in any event delivered to or addressed
as follows:
If to Investor:
Vision International Enterprises, S.A.
522 Balboa Plaza
Balboa Avenue, Panama
Attn: Sara L. de Nunez, President
If to Cavit:
Cavit Sciences, Inc.
100 E. Linton Blvd., Suite 106B
Delray Beach, Florida 33483
Attention: Colm J. King, CEO
14. Counterparts. This Agreement may be signed in two or more counterparts
which counterparts shall constitute a single, integrated agreement binding upon
all the signatories to such counterparts. Delivery of an executed counterpart of
this Agreement by facsimile shall be equally as effective as delivery of a
manually executed counterpart of this Agreement.
15. Expenses. Except as specifically provided otherwise herein, each party
hereto shall pay its or his own expenses arising from this Agreement and the
transactions contemplated hereby, including, without limitation, all legal and
accounting fees and disbursements; provided, however, that nothing herein shall
limit or otherwise modify any right of the parties to recover such expenses
(including legal fees and costs of litigation) from the other in the event any
party hereto breaches this Agreement.
16. Further Assurances. Each of the parties hereto shall hereafter execute
and deliver such further documents and instruments and do such further acts and
things as may be required or useful to carry out the intent and purpose of this
Agreement and as are not inconsistent with the terms hereof.
IN WITNESS WHEREOF, the parties hereto have executed and delivered this
Common Stock Purchase Agreement on the date first written above.
Vision International Enterprises, S.A. Cavit Sciences, Inc.
By: /s/ Sara L. de Nunez By: /s/ Colm J. King
----------------------------- -----------------------------
Sara L. de Nunez Colm J. King,
Title: President Title: Chief Executive Officer
4